Study finds certain drugs cut Alzheimer's

Dec 06, 2006

U.S. scientists say they've identified anti-hypertensive agents that can prevent cognitive decline and amyloid neuropathology in Alzheimer patients.

The research, conducted by Dr. Giulio Maria Pasinetti and colleagues at the Mount Sinai School of Medicine, suggests a large number of geriatric patients under pharmacological treatment for high-blood pressure with certain anti-hypertensive drugs might also reap the benefits of the drug's cognitive effects.

Pasinetti's research is part of a growing push to identify and develop more effective treatments for Alzheimer's disease.

"There is no convincing evidence that there is any available drug presently on the market to cure Alzheimer's disease and there are many questions surrounding the effectiveness of drugs that are available to delay or effectively alleviate symptoms of memory deterioration or dementia," said Pasinetti.

During the past two years, researchers have begun screening drugs already commercially available for treatment of other disorders to determine their potential value in treating Alzheimer's disease and cognitive impairment.

Pasinetti's findings were presented Wednesday in New York during the American College of Neuropsychopharmacology's annual conference.

Copyright 2006 by United Press International

Explore further: Drug research and development more efficient than expected

add to favorites email to friend print save as pdf

Related Stories

Research reveals structure of key CRISPR complex

Dec 10, 2014

Using a gene-editing system originally developed to delete specific genes, MIT researchers have now shown that they can reliably turn on any gene of their choosing in living cells.

Wild sheep show benefits of putting up with parasites

Aug 07, 2014

In the first evidence that natural selection favors an individual's infection tolerance, researchers from Princeton University and the University of Edinburgh have found that an animal's ability to endure ...

The five biggest threats to human existence

May 29, 2014

In the daily hubbub of current "crises" facing humanity, we forget about the many generations we hope are yet to come. Not those who will live 200 years from now, but 1,000 or 10,000 years from now. I use ...

Recommended for you

Drug research and development more efficient than expected

7 hours ago

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.